Marketing-authorisation holder
Phathom
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| VOQUEZNA10mg base | 20mg base · Tablet | Vonoprazan | United States | Marketed | 2023 |
| VOQUEZNA DUAL PAK500mg; 20mg base · Capsule, tablet | Amoxicillin, Vonoprazan | United States | Marketed | 2022 |
| VOQUEZNA TRIPLE PAK500mg; 500mg; 20mg base · Capsule, tablet, tablet | Amoxicillin, Clarithromycin, Vonoprazan | United States | Marketed | 2022 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 3 | 0 | CompaniesAll medicines |
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder
Work with Prognia
Keep Phathom’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call